2025 ACC scientific statement on the management of obesity in adults with heart failure: a report of the American College of Cardiology
Kittleson MM, Benjamin EJ, Blumer V, et al.
J Am Coll Cardiol. Pub. online 10 Jun 2025.
Leggi
Is screening for heart failure and peripheral artery disease warranted in asymptomatic adults with diabetes? A perspective on the 2025 American Diabetes Association “Standards of Care in Diabetes”
Herman WH, Kuo S
Diabetes Care. 2025:dci240103.
Leggi
Associations of time in tight range, time in range, and glycated hemoglobin with albuminuria in type 1 diabetes: a cross-sectional study
Kim JY, Kim S, Park SH, et al.
Diabetes Res Clin Pract. 2025:112325.
Leggi
Prevention of type 2 diabetes in migrant populations from low- and middle-income countries living in high-income countries
Bennet L, Agyemang C
Diabetologia. Pub. online 7 Jun 2025.
Leggi
Post-authorisation safety study to assess the risk of urinary tract cancer in people with type 2 diabetes initiating empagliflozin: a multi-country European study
Schmedt N, Alhamdow A, Tskhvarashvili G, et al.
Diabetes Obes Metab. Pub. online 13 Jun 2025.
Leggi
Cellular adhesion molecules and adverse outcomes in chronic heart failure: findings from the DAPA-HF randomized clinical trial
McDowell K, Welsh P, Docherty KF, et al.
JAMA Cardiol. 2025:e251592.
Leggi
Prevention of atrial fibrillation with SGLT2 inhibitors across the spectrum of cardiovascular disorders: a meta-analysis of randomised controlled trials
Fedele D, Casuso Alvarez M, Maida A, et al.
Eur Heart J Cardiovasc Pharmacother. 2025:pvaf040.
Leggi
Screening accuracy of Single-Point Insulin Sensitivity Estimator (SPISE) for metabolic syndrome: a systematic review and meta-analysis
Azarboo A, Fallahtafti P, Jalali S, et al.
BMC Endocr Disord. 2025;25(1):142.
Leggi
Vegan diet, processed foods, and type 1 diabetes: a secondary analysis of a randomized clinical trial
Kahleova H, Himmelfarb J, Znayenko-Miller T, et al.
Nutr Metab Cardiovasc Dis. Pub. online 13 Jun 2025.
Leggi
Once weekly IcoSema versus once weekly insulin icodec in type 2 diabetes management (COMBINE 1): an open label, multicentre, treat to target, randomised, phase 3a trial
Mathieu C, Giorgino F, Kim SG, et al.
Lancet Diabetes Endocrinol. Pub. online 4 Jun 2025.
Leggi